Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Reliability and Factor Structure.
The role of mitochondria in axonal degeneration and tissue repair in MS.
N-Acetylcysteine amide: A Derivative to Fulfill the Promises of N-Acetylcysteine.
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.
Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
RNF and Betaseron® Tolerability Study (REFORMS)
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Multiple sclerosis: An old drug plays a new trick.
In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.
Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen pharmaceutical companies
A biopsychosocial model of resilience for multiple sclerosis.
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: The particular context of virus infection.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Immune cell trafficking from the brain maintains CNS immune tolerance.
Seeing optic neuritis through myopic eyes.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.

Pages